Ming-Chu Hsu
Director/Board Member chez TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Profil
Ming-Chu Hsu is the founder and currently holds the position of Chairman, President & Chief Executive Officer at TaiGen Biotechnology Co., Ltd., which was founded in 2001.
Dr. Hsu is also a Director at TaiGen Biopharmaceuticals Holdings Ltd.
since 2001.
In the past, Dr. Hsu worked as a Research Director at Hoffmann-La Roche, Inc., Director-Biotechnology & Pharmaceutical Research at National Health Research Institutes, Research Fellow at California Institute of Technology, and Assistant Professor at The Rockefeller University.
Dr. Hsu obtained a doctorate degree from the University of Illinois.
Postes actifs de Ming-Chu Hsu
| Sociétés | Poste | Début |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Director/Board Member | 02/01/2019 |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Chief Executive Officer | 01/01/2001 |
Anciens postes connus de Ming-Chu Hsu
| Sociétés | Poste | Fin |
|---|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Chief Tech/Sci/R&D Officer | - |
| National Health Research Institutes | Corporate Officer/Principal | - |
| The Rockefeller University | Corporate Officer/Principal | - |
Formation de Ming-Chu Hsu
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| National Health Research Institutes |
